Company intelligence / Profile preview

Flowonix Medical

Mt. Olive, New Jersey, United Statesflowonix.com ↗

Ownership: Private
Development stage: Commercial

Overview

Flowonix's Prometra® II Programmable Pump System has received FDA approval for the intrathecal infusion of drugs such as morphine sulfate and baclofen, with demonstrated safety features and long battery life. The system provides precise, programmable drug delivery for chronic pain and severe spasticity in adults and adolescents.

Therapeutic areas: Neurology
Modalities: DeviceImplantable drug delivery system
Industry: Implantable Medical Devices

Drug pipeline

1 asset

baclofen

Commercial

Indications: Severe spasticity

Partnerships

Not explicitly listed; company supports physician education and research collaborations but no major pharma/biotech partnerships are named in public sources.

Beyond the preview

Go deeper on Flowonix Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flowonix Medical.